2 months ago
PFE
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 18%
#903 out of 5147 analysts
Average Return
+27.9%
Win Rate
67%16 out of 24
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Metsera IncMTSR | +157.96% | $27.33 | $70.50 | 2025-02-24 - 2025-11-14 | Strong Buy |
Apogee Therapeutics IncAPGE | +108.98% | $36.62 | $76.53 | 2025-08-27 - 2025-12-11 | Strong Buy |
Metsera IncMTSR | +101.20% | $35.04 | $70.50 | 2025-08-27 - 2025-11-14 | Strong Buy |
Aardvark Therapeutics IncAARD | +83.86% | $8.49 | $15.61 | 2025-08-27 - 2025-12-11 | Strong Buy |
Aardvark Therapeutics IncAARD | +75.39% | $8.90 | $15.61 | 2025-03-26 - 2025-12-11 | Strong Buy |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
5 months ago
JNJ
8 months ago
JNJ
9 months ago
GILD
10 months ago
MRK
a year ago
JNJ
a year ago
JNJ
a year ago
PFE
a year ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 3 | Sell | $627.00 | -16.04% | Maintains | a month ago |
Johnson & JohnsonJNJ | 8 | Hold | $204.00 | -2.86% | Maintains | 2 months ago |
Pfizer IncPFE | 3 | Hold | $30.00 | +16.28% | Maintains | 2 months ago |
Amgen IncAMGN | 5 | Sell | $272.00 | -14.30% | Maintains | 3 months ago |
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $87.00 | +13.68% | Maintains | 3 months ago |
Metsera IncMTSR | 2 | Strong Buy | $50.00 | -29.08% | Maintains | 3 months ago |
Aardvark Therapeutics IncAARD | 3 | Strong Buy | $25.00 | +60.15% | Maintains | 3 months ago |
Abbvie IncABBV | 6 | Hold | $204.00 | -8.92% | Maintains | 7 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $126.00 | +2.26% | Maintains | 9 months ago |
Moderna IncMRNA | 2 | Sell | $34.00 | +14.75% | Maintains | 10 months ago |
Merck & Co IncMRK | 4 | Strong Buy | $112.00 | +13.12% | Maintains | 10 months ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $63.00 | N/A | Reinstates | a year ago |
Biogen IncBIIB | 1 | Hold | $178.00 | N/A | Reinstates | a year ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $997.00 | N/A | Reinstates | a year ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.